Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

See-Tarn Woon

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
The New Zealand Medical Journal|June 30, 2016
The case for a national service for primary immune deficiency disorders in New ZealandRohan Ameratunga, Richard Steele, Anthony Jordan, et al.
Expert Review of Clinical Immunology|March 22, 2021
Perspective: diagnostic laboratories should urgently develop T cell assays for SARS-CoV-2 infectionRohan Ameratunga, See-Tarn Woon, Anthony Jordan, et al.
The New Zealand Medical Journal|October 23, 2025
COVID-19 is a living example of Darwinian natural selection, and SARS-CoV-2 evolution is occurring under (and in) our nosesRohan Ameratunga, Euphemia Y Leung, See-Tarn Woon, et al.
Seminars in Arthritis and Rheumatism|February 8, 2024
The autoimmune rheumatological presentation of Common Variable Immunodeficiency Disorders with an overview of genetic testingRohan Ameratunga, See-Tarn Woon, Euphemia Leung, et al.
Journal of Clinical Immunology|August 13, 2014
Identification of germinal centres in the lymph node of a patient with hyperimmunoglobulin M syndrome associated with congenital rubellaRohan Ameratunga, Chun-Jen J Chen, Wikke Koopmans, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 16, 2023
The Rapidly Expanding Genetic Spectrum of Common Variable Immunodeficiency-Like DisordersRohan Ameratunga, Emily S J Edwards, Klaus Lehnert, et al.
Journal of Clinical Immunology|January 3, 2022
First Identified Case of Fatal Fulminant Necrotizing Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Hypersensitivity ReactionRohan Ameratunga, See-Tarn Woon, Mary N Sheppard, et al.
Anticancer Research|March 14, 2007
NF-kappaB-independent induction of endothelial cell apoptosis by the vascular disrupting agent DMXAASee-Tarn Woon, Sandy S C Hung, Derek C F Wu, et al.
Clinical and Experimental Immunology|August 11, 2023
Soluble wild-type ACE2 molecules inhibit newer SARS-CoV-2 variants and are a potential antiviral strategy to mitigate disease severity in COVID-19Rohan Ameratunga, Emily Mears, Euphemia Leung, et al.
Clinical & Translational Immunology|November 9, 2017
Epistatic interactions between mutations of TACI (<i>TNFRSF13B</i>) and <i>TCF3</i> result in a severe primary immunodeficiency disorder and systemic lupus erythematosusRohan Ameratunga, Wikke Koopmans, See-Tarn Woon, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
The New Zealand Medical Journal|June 30, 2016
The case for a national service for primary immune deficiency disorders in New ZealandRohan Ameratunga, Richard Steele, Anthony Jordan, et al.
Expert Review of Clinical Immunology|March 22, 2021
Perspective: diagnostic laboratories should urgently develop T cell assays for SARS-CoV-2 infectionRohan Ameratunga, See-Tarn Woon, Anthony Jordan, et al.
The New Zealand Medical Journal|October 23, 2025
COVID-19 is a living example of Darwinian natural selection, and SARS-CoV-2 evolution is occurring under (and in) our nosesRohan Ameratunga, Euphemia Y Leung, See-Tarn Woon, et al.
Seminars in Arthritis and Rheumatism|February 8, 2024
The autoimmune rheumatological presentation of Common Variable Immunodeficiency Disorders with an overview of genetic testingRohan Ameratunga, See-Tarn Woon, Euphemia Leung, et al.
Journal of Clinical Immunology|August 13, 2014
Identification of germinal centres in the lymph node of a patient with hyperimmunoglobulin M syndrome associated with congenital rubellaRohan Ameratunga, Chun-Jen J Chen, Wikke Koopmans, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 16, 2023
The Rapidly Expanding Genetic Spectrum of Common Variable Immunodeficiency-Like DisordersRohan Ameratunga, Emily S J Edwards, Klaus Lehnert, et al.
Journal of Clinical Immunology|January 3, 2022
First Identified Case of Fatal Fulminant Necrotizing Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Hypersensitivity ReactionRohan Ameratunga, See-Tarn Woon, Mary N Sheppard, et al.
Anticancer Research|March 14, 2007
NF-kappaB-independent induction of endothelial cell apoptosis by the vascular disrupting agent DMXAASee-Tarn Woon, Sandy S C Hung, Derek C F Wu, et al.
Clinical and Experimental Immunology|August 11, 2023
Soluble wild-type ACE2 molecules inhibit newer SARS-CoV-2 variants and are a potential antiviral strategy to mitigate disease severity in COVID-19Rohan Ameratunga, Emily Mears, Euphemia Leung, et al.
Clinical & Translational Immunology|November 9, 2017
Epistatic interactions between mutations of TACI (<i>TNFRSF13B</i>) and <i>TCF3</i> result in a severe primary immunodeficiency disorder and systemic lupus erythematosusRohan Ameratunga, Wikke Koopmans, See-Tarn Woon, et al.
Pageof 7